In his role as Senior Vice President & Chief Medical Officer at Harvard Pilgrim Health Care, Dr. Sherman is responsible for Harvard Pilgrim’s medical trend management, network medical management, medical informatics, wellness and health promotion initiatives, care and disease management services, pharmacy services, NCQA accreditation and quality and utilization management programs. He also serves as chair of the board of managers of the Harvard Pilgrim Health Care Institute, which includes the Department of Population Medicine at Harvard Medical School. A leader in driving adoption of outcomes-based provider and pharmaceutical contracts, Dr. Sherman has overseen the execution of over a dozen outcomes-based contracts with major pharmaceutical companies that go beyond the current “pay per pill” paradigm.
Dr. Sherman currently serves on the board of advisors for the Harvard Business School Healthcare Initiative, the board of directors for the Personalized Medicine Coalition, and board of overseers for Boston’s internationally renowned Museum of Science. He is also a member of the Advisory Board of the Institute for Clinical and Economic Review (ICER) and is the current chair for AHIP’s CMO Leadership Council, comprised of chief medical officers from health plans throughout the United States. Until recently, he served on the board of directors and as co-president of the Harvard Business School Healthcare Alumni Association.
Dr. Sherman often speaks at national and regional conferences, most frequently on the subject of outcomes-based pharmaceutical agreements, and he has lectured at Harvard Business School, Harvard Medical School and other institutions.
Blockchain and Fintech: Short Courses
5 Mistakes to Avoid in Choosing Executive Education
Getting Your Employer to Pay for Your Training — in 8 Steps